Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4G0T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $135,898
Award facts
- Contract value 100% obligated
- $135,897.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $135,897.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) on January 28, 2026, with completion targeted for January 29, 2026. The contract was awarded without set-aside designation through competitive procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, maintains extensive experience fulfilling DLA requirements across multiple therapeutic domains including diabetes management medications like the Ozempic product specified in this order. The parent company Cencora, Inc., doing business as AmerisourceBergen, competes on a full and open basis for federal contracts and demonstrates consistent capability to deliver specialized pharmaceutical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions across its contract portfolio with the Department of Defense and other government agencies.
Quick answers
Who was awarded contract SPE2DR26F4G0T?
SPE2DR26F4G0T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F4G0T worth?
The government has obligated $135,898 on SPE2DR26F4G0T.
Is contract SPE2DR26F4G0T an order under another contract?
Yes. SPE2DR26F4G0T is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4G0T competed?
The extent of competition for SPE2DR26F4G0T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award